[1]
Liu, H., Yu, Q., Gu, T., Qu, P., Ma, X., Zhou, S., Lu, T., Pan, D. and Han, Z. 2023. Transarterial Chemoembolization plus Apatinib with or without Camrelizumab for the Treatment of Advanced HBV-related Hepatocellular Carcinoma. Journal of Gastrointestinal and Liver Diseases. 32, 2 (Jun. 2023), 182–189. DOI:https://doi.org/10.15403/jgld-4667.